期刊文献+

吉西他滨与氯化钠注射液及不同pH葡萄糖注射液的配伍稳定性 被引量:2

原文传递
导出
摘要 目的:考察盐酸吉西他滨与氯化钠注射液及不同pH葡萄糖注射液在不同温度、光照条件下配伍的稳定性。方法:建立HPLC法测定吉西他滨在不同配伍液中的含量;同时测定不同配伍液的pH值,不溶性微粒,并检查外观。结果:盐酸吉西他滨与0.9%氯化钠注射液配伍后,48 h配伍液的pH值、主药百分含量相对0h变化小于2%;与5%葡萄糖注射液(pH=4.76)配伍后,常温下24 h配伍液的pH值、主药百分含量相对0h变化小于2%,而48 h配伍液的上述变化相对0h超过2%;所有条件下的不溶性微粒均符合2010年版中国药典规定。结论:盐酸吉西他滨于常温条件下可与0.9%氯化钠注射液或5%葡萄糖注射液配伍,配伍后应在24 h内尽快完成临床输注。
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2013年第2期167-168,共2页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献2

二级参考文献19

  • 1Kosmas C, Tsavaris N, Mylonakis, et al. An overview of current resuits with the gemcitabine and docetaxel combination as initial and salvage chemotherapy regimen in advanced non - small - cell lung cancer. Crit Rew Oncol Hemato1,2003,45 ( 3 ) :265.
  • 2Heinemarm V. Role of gemcitabine in the treatment of advanced and metastatic breast cancer. Oncology,2003,64 ( 3 ) : 191.
  • 3Moore MJ, Harem J, Dancey J, et al. Comparison of gemcitabine versus the matrix metaUop - roteinase inhibitor BAY - 12 - 9566 in patients with advanced or metastatic adof the pancreas:a phase Ⅲ trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol,2003,21 (17) :3296.
  • 4Abbruzzese JL, Grunewald R, Weeks EA, et al. A phase I clinical : plasma and cellular pharmacology study of gemcitabine. J Clin Oncol,1991,9( 3 ) :491.
  • 5Shipley LA, Brown TJ, Compropst JD, et al. Metabolism and disposition of gemcitabine: an oncolytic deoxycytidine analog in mice,rats and dogs. Drug Metab Dispos,1992,20(6) :849.
  • 6Kerr JZ, Berg SL, Dauser R, et al. Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration innonhuman primates. Cancer Chemother Pharmacol, 2001,47 (5) :411.
  • 7Kiani A, Kohne CH, Franz T, et al. Pharmacokinetics of gemcitabine in a patient with end - stage renal disease : effective clearance of its main metabolite by standard hemodialysis treatment.Cancer Chemother Pharmacol,2003,51 (3) :266.
  • 8Pestieau SR,Stuart OA,Chang D,et al. Pharmacokinetics of intraperitoneal gemcitabine in rat model. Tumori,1998,84(6) :706.
  • 9Freeman KB,Anliker S,Hamilton M,et al. Validated assays for thedetermination of gemcitabine in human plasma and urine using high - performance liquid chromatography with ultraviolet detection. J Chromamgr B, 1995,665 ( 1 ) : 171.
  • 10Shord SS, Faucette SR, Gilhnwater HH ,et al. Gemcitabine pharmacokinetics and intemctlon with paclitaxel in patients with advanced non- small - cell lung cancer. Cancer Chemother Pharmacol,2003,51 (4) :328.

共引文献18

同被引文献19

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部